Dr. Rajadas is currently working on the molecular mechanisms of neurodegenerative disorders caused by aggregated tau and Abeta proteins that are synergically involved in Alzheimer's disease development. He uses various biophysical approaches such as AFM, fluorescence, and NMR to understand the structural details of these two proteins' neurotoxic oligomeric forms.
For the past 10 years, our lab has also been involved in transforming biophysical ideas into biomaterial and drug delivery technologies. These technologies include microencapsulation of drugs, vascular grafts, bio-implants, development of small molecule and protein-based drugs, regeneration of nerve and cardiovascular tissues, and wound healing applications.
- Founding Director, Advanced Drug Delivery and Regenerative Biomaterials Laboratory, Stanford Cardiovascular Institute (2020 - Present)
- Assistant Director, Cardiovascular Pharmacology, Stanford school of medicine (2013 - Present)
- Founding Director, Biomaterials and Advanced Drug Delivery Lab, Stanford School of Medicine (2009 - 2019)
- Instructor, Neurology and Neurological Sciences, Stanford University School of Medicine (2007 - 2012)
- Consulting Professor, Department of Chemical Engineering, Stanford University (2005 - 2007)
- Visiting Professor, Department of Biological Sciences, Stanford University (2003 - 2005)